{
    "N/R/U": null,
    "Applicant": "GlaxoSmithKline Biologicals",
    "BLA Number": "125265",
    "Proprietary Name": "Rotarix",
    "Proper Name": "Rotavirus Vaccine, Live, Oral",
    "BLA Type": "351(a)",
    "Strength": "106.0CCID50",
    "Dosage Form": "Suspension",
    "Route of Administration": "Oral",
    "Product Presentation": "Tube",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "November 04, 2022",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "645",
    "Submission Type": "Supplement",
    "License Number": "1617",
    "Product Number": "002",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "Rotavirus Vaccine, Live, Oral",
            "drugbank_id": "https://go.drugbank.com/drugs/DB10276"
        }
    ]
}